HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-NOV-03 1RDQ TITLE HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT TITLE 2 PROTEIN KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: E; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, ALPHA FORM; COMPND 10 CHAIN: I; COMPND 11 FRAGMENT: RESIDUES 5-24; COMPND 12 SYNONYM: PKI-ALPHA, CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 13 MUSCLE/BRAIN ISOFORM; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: THE PROTEIN WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 11 OF THE PROTEIN IS NATURALLY FOUND IN MUS MUSCULUS (MOUSE) KEYWDS CAMP-DEPENDENT PROTEIN KINASE, CATALYTIC MECHANISM, ATP HYDROLYSIS, KEYWDS 2 TWO NUCLEOTIDE STATES, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.YANG,L.F.TEN EYCK,N.H.XUONG,S.S.TAYLOR REVDAT 8 30-OCT-24 1RDQ 1 REMARK REVDAT 7 23-AUG-23 1RDQ 1 REMARK REVDAT 6 27-OCT-21 1RDQ 1 REMARK SEQADV LINK REVDAT 5 31-JAN-18 1RDQ 1 JRNL REVDAT 4 22-JAN-14 1RDQ 1 REMARK REVDAT 3 13-JUL-11 1RDQ 1 VERSN REVDAT 2 24-FEB-09 1RDQ 1 VERSN REVDAT 1 13-APR-04 1RDQ 0 JRNL AUTH J.YANG,L.F.TEN EYCK,N.H.XUONG,S.S.TAYLOR JRNL TITL CRYSTAL STRUCTURE OF A CAMP-DEPENDENT PROTEIN KINASE MUTANT JRNL TITL 2 AT 1.26A: NEW INSIGHTS INTO THE CATALYTIC MECHANISM. JRNL REF J.MOL.BIOL. V. 336 473 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 14757059 JRNL DOI 10.1016/J.JMB.2003.11.044 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH MADHUSUDAN,P.AKAMINE,N.H.XUONG,S.S.TAYLOR REMARK 1 TITL CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE REMARK 1 TITL 2 CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REMARK 1 REF NAT.STRUCT.BIOL. V. 9 273 2002 REMARK 1 REFN ISSN 1072-8368 REMARK 1 DOI 10.1038/NSB780 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.ZHENG,D.R.KNIGHTON,L.F.TEN EYCK,R.KARLSSON,N.H.XUONG, REMARK 1 AUTH 2 S.S.TAYLOR,SOWADSKI J.M. REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 1 TITL 2 PROTEIN KINASE COMPLEXED WITH MGATP AND PEPTIDE INHIBITOR REMARK 1 REF BIOCHEMISTRY V. 32 2154 1993 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH P.AKAMINE,MADHUSUDAN,J.WU,N.H.XUONG,L.F.TEN EYCK,S.S.TAYLOR REMARK 1 TITL DYNAMIC FEATURES OF CAMP-DEPENDENT PROTEIN KINASE REVEALED REMARK 1 TITL 2 BY APOENZYME CRYSTAL STRUCTURE REMARK 1 REF J.MOL.BIOL. V. 327 159 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1016/S0022-2836(02)01446-8 REMARK 2 REMARK 2 RESOLUTION. 1.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.132 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.162 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 5630 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 122674 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2891 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 439 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.060 REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED CNS SOLVE 1.0, THEN SHELXL97 FOR REMARK 3 ANISOTROPIC REFINEMENT. THE R FACTOR VALUES USED FOR REFINEMENT REMARK 3 SHELL ARE ISOTROPIC B REMARK 4 REMARK 4 1RDQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020669. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 114998 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.260 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.25300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1APM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MPD, BICINE, AMMONIUM ACETATE, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.88000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.86950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.75650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.86950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.88000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.75650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA E 6 REMARK 465 LYS E 7 REMARK 465 LYS E 8 REMARK 465 GLY E 9 REMARK 465 SER E 10 REMARK 465 GLU E 11 REMARK 465 GLN E 12 REMARK 465 GLU E 13 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS E 16 CG CD CE NZ REMARK 470 LYS E 21 CG CD CE NZ REMARK 470 GLU E 24 CD OE1 OE2 REMARK 470 LYS E 78 CD CE NZ REMARK 470 LYS E 81 CD CE NZ REMARK 470 LYS E 83 CE NZ REMARK 470 GLN E 176 CG CD OE1 NE2 REMARK 470 GLU E 248 CG CD OE1 OE2 REMARK 470 LYS E 254 CE NZ REMARK 470 ARG E 256 CD NE CZ NH1 NH2 REMARK 470 LYS E 285 CG CD CE NZ REMARK 470 LYS E 295 CD CE NZ REMARK 470 ILE E 315 CG1 CG2 CD1 REMARK 470 LYS E 317 CG CD CE NZ REMARK 470 PHE E 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS E 319 CG CD CE NZ REMARK 470 GLU E 333 CD OE1 OE2 REMARK 470 GLU E 334 CG CD OE1 OE2 REMARK 470 ASN I 520 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG E 137 CD - NE - CZ ANGL. DEV. = 13.3 DEGREES REMARK 500 ARG E 144 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG E 190 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG E 336 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA E 4 137.87 -39.22 REMARK 500 ASP E 166 49.50 -148.95 REMARK 500 ASP E 184 81.19 64.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG E 601 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN E 171 OD1 REMARK 620 2 ASP E 184 OD2 96.0 REMARK 620 3 PO4 E 598 O4 100.3 87.9 REMARK 620 4 ADP E 599 O2A 92.4 89.1 167.3 REMARK 620 5 ADP E 599 O3B 175.9 87.8 81.4 86.1 REMARK 620 6 ATP E 600 O2A 93.7 88.8 165.9 1.3 84.8 REMARK 620 7 ATP E 600 O3B 176.6 86.9 77.9 89.6 3.6 88.3 REMARK 620 8 ATP E 600 O2G 109.6 86.0 9.4 157.9 72.2 156.6 68.7 REMARK 620 9 HOH E1146 O 86.3 177.7 92.1 90.5 89.9 90.7 90.9 93.6 REMARK 620 N 1 2 3 4 5 6 7 8 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG E 602 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP E 184 OD1 REMARK 620 2 ASP E 184 OD2 59.2 REMARK 620 3 PO4 E 598 O2 148.2 89.5 REMARK 620 4 ADP E 599 O1B 90.1 87.7 94.1 REMARK 620 5 ATP E 600 O1B 88.2 87.6 96.3 2.2 REMARK 620 6 ATP E 600 O3G 153.4 94.2 7.0 89.1 91.3 REMARK 620 7 HOH E1028 O 97.3 155.6 114.4 85.5 84.7 109.1 REMARK 620 8 HOH E1029 O 85.2 92.3 91.4 174.5 172.3 96.4 92.2 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 E 598 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG E 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG E 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP E 599 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP E 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD E 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL E 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ATP RELATED DB: PDB REMARK 900 THE WILD TYPE PROTEIN WITH SAME LIGANDS ATP AND INHIBITORY PEPTIDE DBREF 1RDQ E 1 350 UNP P05132 KAPCA_MOUSE 1 350 DBREF 1RDQ I 505 524 PDB 1RDQ 1RDQ 505 524 SEQADV 1RDQ TPO E 197 UNP P05132 THR 197 MODIFIED RESIDUE SEQADV 1RDQ ALA E 204 UNP P05132 TYR 204 ENGINEERED MUTATION SEQADV 1RDQ SEP E 338 UNP P05132 SER 338 MODIFIED RESIDUE SEQRES 1 E 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 E 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 E 350 LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA GLN SEQRES 4 E 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 E 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 E 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 E 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 E 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 E 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 E 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 E 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 E 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 E 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 E 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 E 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 E 350 TRP TPO LEU CYS GLY THR PRO GLU ALA LEU ALA PRO GLU SEQRES 17 E 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 E 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 E 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 E 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 E 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 E 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 E 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 E 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 E 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 E 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 E 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 1RDQ TPO E 197 THR PHOSPHOTHREONINE MODRES 1RDQ SEP E 338 SER PHOSPHOSERINE HET TPO E 197 11 HET SEP E 338 10 HET PO4 E 598 5 HET MG E 601 1 HET MG E 602 1 HET ADP E 599 27 HET ATP E 600 31 HET MRD E 800 8 HET GOL E 700 6 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM PO4 PHOSPHATE ION HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM GOL GLYCEROL HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 PO4 O4 P 3- FORMUL 4 MG 2(MG 2+) FORMUL 6 ADP C10 H15 N5 O10 P2 FORMUL 7 ATP C10 H16 N5 O13 P3 FORMUL 8 MRD C6 H14 O2 FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *439(H2 O) HELIX 1 1 SER E 14 THR E 32 1 19 HELIX 2 2 GLN E 39 ASP E 41 5 3 HELIX 3 3 LYS E 76 LEU E 82 1 7 HELIX 4 4 GLN E 84 GLN E 96 1 13 HELIX 5 5 GLU E 127 GLY E 136 1 10 HELIX 6 6 SER E 139 LEU E 160 1 22 HELIX 7 7 LYS E 168 GLU E 170 5 3 HELIX 8 8 THR E 201 LEU E 205 5 5 HELIX 9 9 ALA E 206 LEU E 211 1 6 HELIX 10 10 LYS E 217 GLY E 234 1 18 HELIX 11 11 GLN E 242 GLY E 253 1 12 HELIX 12 12 SER E 262 LEU E 273 1 12 HELIX 13 13 VAL E 288 ASN E 293 1 6 HELIX 14 14 HIS E 294 ALA E 298 5 5 HELIX 15 15 ASP E 301 GLN E 307 1 7 HELIX 16 16 THR I 505 ALA I 512 1 8 SHEET 1 A 5 PHE E 43 THR E 51 0 SHEET 2 A 5 ARG E 56 HIS E 62 -1 O VAL E 57 N GLY E 50 SHEET 3 A 5 HIS E 68 ASP E 75 -1 O MET E 71 N MET E 58 SHEET 4 A 5 ASN E 115 GLU E 121 -1 O MET E 118 N LYS E 72 SHEET 5 A 5 LEU E 106 LYS E 111 -1 N PHE E 110 O TYR E 117 SHEET 1 B 2 LEU E 162 ILE E 163 0 SHEET 2 B 2 LYS E 189 ARG E 190 -1 O LYS E 189 N ILE E 163 SHEET 1 C 2 LEU E 172 ILE E 174 0 SHEET 2 C 2 ILE E 180 VAL E 182 -1 O GLN E 181 N LEU E 173 SHEET 1 D 2 CYS E 199 GLY E 200 0 SHEET 2 D 2 ILE I 522 HIS I 523 -1 O ILE I 522 N GLY E 200 LINK C TRP E 196 N TPO E 197 1555 1555 1.34 LINK C TPO E 197 N LEU E 198 1555 1555 1.33 LINK C VAL E 337 N SEP E 338 1555 1555 1.31 LINK C SEP E 338 N ILE E 339 1555 1555 1.33 LINK OD1 ASN E 171 MG MG E 601 1555 1555 2.06 LINK OD2 ASP E 184 MG MG E 601 1555 1555 2.03 LINK OD1 ASP E 184 MG MG E 602 1555 1555 2.23 LINK OD2 ASP E 184 MG MG E 602 1555 1555 2.20 LINK O4 APO4 E 598 MG MG E 601 1555 1555 1.74 LINK O2 APO4 E 598 MG MG E 602 1555 1555 1.95 LINK O2AAADP E 599 MG MG E 601 1555 1555 1.97 LINK O3BAADP E 599 MG MG E 601 1555 1555 2.11 LINK O1BAADP E 599 MG MG E 602 1555 1555 2.09 LINK O2ABATP E 600 MG MG E 601 1555 1555 1.89 LINK O3BBATP E 600 MG MG E 601 1555 1555 2.31 LINK O2GBATP E 600 MG MG E 601 1555 1555 2.13 LINK O1BBATP E 600 MG MG E 602 1555 1555 2.03 LINK O3GBATP E 600 MG MG E 602 1555 1555 2.05 LINK MG MG E 601 O HOH E1146 1555 1555 2.01 LINK MG MG E 602 O HOH E1028 1555 1555 2.07 LINK MG MG E 602 O HOH E1029 1555 1555 2.10 SITE 1 AC1 13 SER E 53 PHE E 54 ASP E 166 LYS E 168 SITE 2 AC1 13 ASN E 171 ASP E 184 THR E 201 ADP E 599 SITE 3 AC1 13 MG E 601 MG E 602 HOH E1029 HOH E1146 SITE 4 AC1 13 ALA I 521 SITE 1 AC2 6 ASN E 171 ASP E 184 PO4 E 598 ADP E 599 SITE 2 AC2 6 ATP E 600 HOH E1146 SITE 1 AC3 6 ASP E 184 PO4 E 598 ADP E 599 ATP E 600 SITE 2 AC3 6 HOH E1028 HOH E1029 SITE 1 AC4 26 GLY E 50 GLY E 52 SER E 53 PHE E 54 SITE 2 AC4 26 GLY E 55 VAL E 57 ALA E 70 LYS E 72 SITE 3 AC4 26 VAL E 104 MET E 120 GLU E 121 VAL E 123 SITE 4 AC4 26 GLU E 127 GLU E 170 ASN E 171 LEU E 173 SITE 5 AC4 26 THR E 183 ASP E 184 PHE E 327 PO4 E 598 SITE 6 AC4 26 MG E 601 MG E 602 HOH E1028 HOH E1035 SITE 7 AC4 26 HOH E1146 ARG I 518 SITE 1 AC5 29 GLY E 50 GLY E 52 SER E 53 PHE E 54 SITE 2 AC5 29 GLY E 55 VAL E 57 ALA E 70 LYS E 72 SITE 3 AC5 29 VAL E 104 MET E 120 GLU E 121 VAL E 123 SITE 4 AC5 29 GLU E 127 ASP E 166 LYS E 168 GLU E 170 SITE 5 AC5 29 ASN E 171 LEU E 173 THR E 183 ASP E 184 SITE 6 AC5 29 PHE E 327 MG E 601 MG E 602 HOH E1020 SITE 7 AC5 29 HOH E1028 HOH E1029 HOH E1035 HOH E1146 SITE 8 AC5 29 ARG I 518 SITE 1 AC6 5 VAL E 15 PHE E 18 LEU E 152 GLU E 155 SITE 2 AC6 5 TYR E 306 SITE 1 AC7 8 ASP E 44 ARG E 45 PRO E 141 HOH E1147 SITE 2 AC7 8 HOH E1171 HOH E1275 HOH E1315 HOH E1408 CRYST1 57.760 79.513 97.739 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017313 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012577 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010231 0.00000